AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy

NCT03308604 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Gynecologic Cancer

Interventions

DRUG: Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
RADIATION: External beam radiotherapy (EBRT)
RADIATION: Uterovaginal brachytherapy
DRUG: Chemotherapy (cisplatin)

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]